Boston, MA, June 17, 2021
HD LifeSciences, LLC is excited to announce that medical device veteran Tim Jette has joined the company as Chief Financial Officer.
Tim brings significant finance leadership experience within the medtech industry, helping organizations scale for profitable growth. He spent over 25 years at Medtronic in a variety of increasingly progressive financial roles and has extensive experience in commercial channel strategy, global business unit support, complex manufacturing networks, M&A and acquisition integration and technical accounting. Most recently, Tim worked at Medtronic as CFO of the Americas Cardiac and Vascular Group, helping drive growth in a $6B commercial channel. Prior to that, served as CFO for the Global Structural Heart Business, helping launch the transcatheter heart valve in Europe and the US.
Patrick O’Donnell, President & CEO of HD Lifesciences, states “We are very pleased to welcome Tim to our growing team of industry veterans. I’m particularly excited to have a talented and experienced partner as we embark upon raising growth capital to drive our next stages of value building and commercial growth for our innovative HiveTM portfolio of 3D printed titanium interbody products.”
Tim began his career as a CPA with Coopers & Lybrand in Boston and holds a BS in Finance/Accounting from Boston College, as well as an MBA from the University of Chicago Booth Graduate School of Business.
“I’m excited to join the team at HD LifeSciences as we begin to scale our innovative technology within the spinal market”, said Tim Jette.
————————————————
About HD LifeSciences HD LifeSciences is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium™ technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences.
HD Lifesciences is located in Woburn, Massachusetts U.S.A
Contact: Patrick O’Donnell at patrick.odonnell@hdlifesciences.com
Website: www.hdlifesciences.com
